Hematological conditions treated in IHBT
Hematological conditions treated in IHBT:
- Acute myeloid leukemia
- Acute lymphoblastic leukemia
- Acute promyelocytic leukemia
- Myelodysplastic syndromes
- Chronic myeloid leukemia
- Chronic lymphocytic leukemia
- Ph-negative myeloproliferative disorders (polycythemia vera, primary myelofibrosis, essential thrombocythemia)
- Myelodysplastic/myeloproliferative diseases (chronic myelomonocytic leukemia)
Mast cell and eosinophils´disease (hypereosinophilic syndrome, systemic mastocytosis)
- Thrombotic thrombocytopenic purpura
- Idiopathic thrombocytopenic purpura
- Disseminated intravascular coagulation
- Thrombotic disorders inherited or acquired
- Bleeding disorders inherited or acquired (hemophilia A (factor VIII deficiency), hemophilia B (factor IX deficiency), von Willebrand disease, and rare factor deficiencies)
- Hemolytic anemia inherited or acquired
- Paroxysmal nocturnal hemoglobinuria
- Rare red blood cells disorders (hemoglobinopathies, thalassemia…)
- Bone marrow failure syndromes
- Aplastic anemia
- Graft versus Host Disease
- Infectious complications of hematological treatment
- Invasive mycosis
- CMV reactivation
- Febrile neutropenia
- Sepsis
Specialized treatment methods performed at IHTB:
- Allogeneic stem cell transplantation
- CAR-T cell therapy (acute lymphoblastic leukemia, Non-Hodgkin's lymphoma)
- extracorporeal photopheresis, plasmapheresis, immunoadsorption